April 02, 2012
Bronchi-Shield ORAL – First Oral Bordetella bronchiseptica Vaccine Approved for Use in Dogs
Veterinarians have a new, innovative vaccine choice available for protection from the primary pathogen of canine infectious respiratory disease (CIRD). The vaccine, Bronchi-Shield® ORAL from Boehringer Ingelheim Vetmedica, Inc. (BIVI), recently has been approved by the USDA for use in dogs. This vaccine is unique because it is the first live, avirulent Bordetella bronchiseptica vaccine licensed to be administered orally to dogs .
Continue reading Oral Bordetella Vaccine Approved